C. Frank Bennett

Pennsylvania State University — United States

Medicine · Health Sciences

100h-index46.4kcitations329works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neurogenetic and Muscular Disorders Research(72), RNA Interference and Gene Delivery(69), RNA Research and Splicing(67), RNA modifications and cancer(53), DNA and Nucleic Acid Chemistry(48)

Publications329 total

Designing ELT Corpus-Based Materials Using Learner Needs
Second Language Teacher Education·2026
Halofuginone Suppresses Hepcidin by a Heparan Sulfate-dependent Mechanism to Treat Iron Disorders in Mice
Blood Advances·2026Open Access
Assessing and Enhancing Student Engagement
2026
Rethinking Notional Hours for Greater Learner Autonomy and Engagement
2026
Understanding Learner Autonomy and Self-Regulated Learning
2026
The Role of Notional Hours in Curriculum Design
2026
Designing Interactive and Engaging Learning Experiences
2026
Policy and Institutional Support for Innovative Education
2026
Principles and Learning Theories Behind Blended Learning
2026
Suppression of Huntington’s Disease Somatic Instability by Transcriptional Repression and Direct CAG Repeat Binding
Nature Communications·2025Open Access
Preclinical evaluation of antisense oligonucleotide therapy in a mouse model of <i>HNRNPH2</i> -related neurodevelopmental disorder
2025Open Access
A splice-switching antisense oligonucleotide approach for pediatric genetic epilepsies
2025Open Access
Individualized Antisense Oligonucleotides for SCN2A Related Developmental Epileptic Encephalopathy
2025Open Access
Therapeutic targeting of alternative splicing caused by a lethal noncoding structural variant in X-linked dystonia parkinsonism
2025Open Access
Enhanced splicing modulation by NMA-modified antisense oligonucleotides
2025· 1 citedOpen Access
An alternative cytoplasmic SFPQ isoform with reduced phase separation potential is up-regulated in ALS
Science Advances·2025· 2 citedOpen Access
Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case series
The Lancet·2025· 20 citedOpen Access
Intra-amniotic antisense oligonucleotide treatment improves phenotypes in preclinical models of spinal muscular atrophy
Science Translational Medicine·2025· 14 citedOpen Access
Therapeutic Targeting of Alternative Splicing Caused by a Lethal Noncoding Structural Variant in X-Linked Dystonia Parkinsonism
SSRN Electronic Journal·2025Open Access
Antisense oligonucleotide drugs for neurological and neuromuscular diseases
Elsevier eBooks·2024
page 1 of 17Next →

Frequent Co-authors

Frank Rigo(13), Gene Hung(8), Don W. Cleveland(7), Adrian R. Krainer(7), Kathie M. Bishop(6), Daniel A. Norris(6), John Ravits(6), Yimin Hua(6), Susan M. Freier(5), Claudia A. Chiriboga(5), Jacqueline Montes(5), Darryl C. De Vivo(5), Clotilde Lagier‐Tourenne(5), Holly Kordasiewicz(5), Eric E. Swayze(5), Brenda F. Baker(5), Michael W. Baughn(5), Basil T. Darras(4), Eugene Schneider(4), Shuo‐Chien Ling(4)